Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Colonic Neoplasms 1

Interventions

Fluorouracil 18Oxaliplatin 17Capecitabine 16Leucovorin 13Cisplatin 12Gemcitabine 11Drug Therapy 11Irinotecan 10Radiosurgery 9Cetuximab 9Bevacizumab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Cyclophosphamide 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Fecal Microbiota Transplantation × Clear all
NCT04116775 2022-06-23

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Portland VA Medical Center

Phase 2 Unknown
32 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡